CD8A and neoplasm: In addition, Li et al. (2018) showed that complete loss of Eomes impaired the development of anti-tumor cytotoxic T lymphocytes (CTLs), whereas deletion of one allele mitigated CD8+ T-cell exhaustion and offered better tumor control [172].